Marta Miszczuk

Marta Miszczuk

Auto-generated profile, based on publicly available information

Marta Miszczuk

Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, Warsaw, Poland

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
PDF file
AKAleksander Kania
Aleksander Kania
RKRafal Krenke
Rafal Krenke
Krzysztof KuziemskiKrzysztof Kuziemski
Krzysztof Kuziemski
MCMałgorzata Czajkowska-Malinowska
Małgorzata Czajkowska-Malinowska
NCNatalia Celejewska-Wójcik
Natalia Celejewska-Wójcik
ABAdam Barczyk
Adam Barczyk
Background: This study aimed to examine the distribution of predefined phenotypes, demographic data, clinical outcomes, and treatment of patients who were included in the Polish cohort of the Phenotypes of COPD in Central and Eastern Europe (POPE) study. Patients and methods: This was a sub-analysis of the data from the Polish cohort of the POPE study, an international, multicenter, observational cross-sectional survey of COPD patients in Central and Eastern European countries. The study included patients aged .40 years, with a confirmed diagnosis of COPD, and absence of exacerbation for at least 4 weeks before study inclusion. A total of seven Polish centers participated in the study. Results: Among the 430 Polish COPD patients enrolled in the study, 61.6% were non-exacerbators (NON-AE), 25.3% were frequent exacerbators with chronic bronchitis (AE CB), 7.9% were frequent exacerbators without chronic bronchitis (AE NON-CB), and 5.1% met the definition of asthma-COPD overlap syndrome (ACOS). There were statistically significant differences among these phenotypes in terms of symptom load, lung function, comorbidities, and treatment. Patients with the AE CB phenotype were most symptomatic with worse lung function, and more frequently reported anxiety and depression. Patients with the ACOS phenotype were significantly younger and were diagnosed with COPD earlier than those with other COPD phenotypes; those with the ACOS phenotype were also more often atopic and obese. Conclusion: There is significant heterogeneity among COPD patients in the Polish population in terms of phenotype and clinical outcome. The non-exacerbator phenotype is observed most frequently in Poland, while the frequent exacerbator with chronic bronchitis phenotype is the most symptomatic.

1 September 2017
Verified
Conference Paper
Closed access
MDMarta Dąbrowska
Marta Dąbrowska
ŁKŁuczak Katarzyna
Łuczak Katarzyna
MMMarta Miszczuk
Marta Miszczuk
IDIzabela Domagała
Izabela Domagała
WLWojciech Lubański
Wojciech Lubański
RKRafal Krenke
Rafal Krenke
Introduction: A significant number of patients with asthma and COPD do not use inhalers properly. Improper inhaler use may result in poor disease control. Aim: To determine the efficacy of a short training of inhaler use on the course of asthma or COPD. Material and Methods: Adults with asthma or COPD who used at least one inhaler on a regular basis were included. The patients were randomized to a single short training of inhalation technique (STIT) or control (C). The control patients were educated, but their inhalation technique was not corrected. Symptoms severity, number of exacerbations, quality of life (measured by AQLQ or SGRQ) and number of mistakes in inhalation technique were analyzed. The efficacy of training was checked after 3 and 6 months. The outcome measures were compared between STIT and C groups, as well as within groups, i.e. before and after intervention. Results: Of the 100 patients enrolled, 90 (90%) completed the study (asthma – 45 patients, COPD – 45 patients). Of these, 47 patients were randomized to intervention, while 43 were controls. The reduction in number of mistakes made during inhalation was found in 52/90 (58%) subjects. Smaller percentage of educated patients made mistakes during inhalation than controls (32/47 vs 20/43, p=0.0385). The relative benefit was 1.46 (95%CI 1.005 -2.131, p=0.046). NNT was 4.6 (95%CI 2.4-61). However, there was neither significant reduction in exacerbation rate and symptom control, nor significant improvement in quality of life. Conclusions: A short, single training of proper inhalation technique leads to a reduction of the number of mistakes made during inhalation, but it doesn’t influence the course of asthma or COPD.